The ADINA Act requires drug labels to identify ingredients that are major food allergens or gluten-containing grains.
The ADINA Act amends the Federal Food, Drug, and Cosmetic Act to mandate that drug labels for human use must identify each ingredient derived from major food allergens or gluten-containing grains. This includes specifying the type of gluten-containing grain. The requirement applies to drugs with such ingredients, and failure to label them correctly results in misbranding. The rule takes effect either on a date set by the Secretary of Health and Human Services or two years after the Act's enactment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.